These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19937426)

  • 1. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study.
    Berry SD; Kiel DP; Donaldson MG; Cummings SR; Kanis JA; Johansson H; Samelson EJ
    Osteoporos Int; 2010 Jan; 21(1):53-60. PubMed ID: 19937426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
    Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
    Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data.
    Kim JW; Jeon YJ; Baek DH; Kim TN; Chang JS
    Osteoporos Int; 2014 Apr; 25(4):1313-9. PubMed ID: 24345885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
    Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
    Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines.
    Donaldson MG; Cawthon PM; Lui LY; Schousboe JT; Ensrud KE; Taylor BC; Cauley JA; Hillier TA; Dam TT; Curtis JR; Black DM; Bauer DC; Orwoll ES; Cummings SR;
    J Bone Miner Res; 2010 Jul; 25(7):1506-11. PubMed ID: 20200971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.
    Ensrud KE; Taylor BC; Peters KW; Gourlay ML; Donaldson MG; Leslie WD; Blackwell TL; Fink HA; Orwoll ES; Schousboe J;
    BMJ; 2014 Jul; 349():g4120. PubMed ID: 24994809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive undertreatment of osteoporosis in older Swedish women.
    Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
    Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of morphometric radiographic vertebral assessment for the detection of patients who need pharmacological treatment of osteoporosis among postmenopausal diabetic Korean women.
    Choi YJ; Yang SO; Shin CS; Chung YS
    Osteoporos Int; 2012 Aug; 23(8):2099-2105. PubMed ID: 21975560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008.
    Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
    Osteoporos Int; 2012 Mar; 23(3):811-20. PubMed ID: 21717247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative bone health assessment and optimization in spine surgery.
    Anderson PA; Kadri A; Hare KJ; Binkley N
    Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Hoff M; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Skovlund E; Abrahamsen B; Forsmo S; Schei B
    Osteoporos Int; 2018 Aug; 29(8):1875-1885. PubMed ID: 29774403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment implications for men when switching from male to female bone mineral density reference data: the Manitoba Bone Density Program.
    Leslie WD; Majumdar SR
    J Clin Densitom; 2013; 16(4):537-42. PubMed ID: 24090643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Wright NC; Saag KG; Dawson-Hughes B; Khosla S; Siris ES
    Osteoporos Int; 2017 Apr; 28(4):1225-1232. PubMed ID: 27966104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of osteoporosis in non-neck of femur fragility fractures: is it value for money? A retrospective, prospective and cross-sectional cohort study.
    Mettyas T; Carpenter C
    J Orthop Surg Res; 2013 Dec; 8():44. PubMed ID: 24289492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.
    Wang CC; Wu CH; Farley JF
    Ann Pharmacother; 2015 Sep; 49(9):995-1003. PubMed ID: 26041809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.
    Adler RA; Hastings FW; Petkov VI
    Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk assessment without bone density measurement in routine clinical practice.
    Leslie WD; Morin S; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Jan; 23(1):75-85. PubMed ID: 21850546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of women aged 50-64 yr for bone density measurement.
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    J Clin Densitom; 2013; 16(4):570-8. PubMed ID: 23452870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.